These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19348235)

  • 21. The role of tumor necrosis factor-alpha in inducing insulin resistance in the renin-angiotensin system.
    Iwai M; Mogi M; Horiuchi M
    Hypertens Res; 2005 Sep; 28(9):701-2. PubMed ID: 16419641
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The implication of renin-angiotensin system on renal injury seen in Dahl salt-sensitive rats.
    Hirawa N; Uehara Y; Numabe A; Kawabata Y; Gomi T; Ikeda T; Ohnishi T; Ishii M; Omata M
    Am J Hypertens; 1997 May; 10(5 Pt 2):102S-106S. PubMed ID: 9160791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RAA system and cardiovascular control in normal subjects, hypertensives and patients with congestive heart failure.
    Seravalle G; Cattaneo BM; Giannattasio C; Perondi R; Saino A; Grassi G; Mancia G
    J Hum Hypertens; 1993 Aug; 7 Suppl 2():S13-8. PubMed ID: 8230084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventing diabetes in patients with hypertension: one more reason to block the renin-angiotensin system.
    Cooper ME; Tikellis C; Thomas MC
    J Hypertens Suppl; 2006 Mar; 24(1):S57-63. PubMed ID: 16601575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
    Kurita S; Takamura T; Ota T; Matsuzawa-Nagata N; Kita Y; Uno M; Nabemoto S; Ishikura K; Misu H; Ando H; Zen Y; Nakanuma Y; Kaneko S
    Eur J Pharmacol; 2008 Jul; 588(2-3):316-24. PubMed ID: 18501344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pathology and treatment of renin-angiotensin system 4. Renin-angiotensin system and insulin resistance.
    Shimamoto K; Miura T
    Intern Med; 2007; 46(16):1303-4. PubMed ID: 17704610
    [No Abstract]   [Full Text] [Related]  

  • 28. Angiotensin II and the development of insulin resistance: implications for diabetes.
    Olivares-Reyes JA; Arellano-Plancarte A; Castillo-Hernandez JR
    Mol Cell Endocrinol; 2009 Apr; 302(2):128-39. PubMed ID: 19150387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.
    Ran J; Hirano T; Fukui T; Saito K; Kageyama H; Okada K; Adachi M
    Metabolism; 2006 Apr; 55(4):478-88. PubMed ID: 16546478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evidence for the cardiovascular benefits of angiotensin receptor blockers.
    Nickenig G; Ostergren J; Struijker-Boudier H
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7 Suppl 1():S1-7. PubMed ID: 16969748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The renin-angiotensin-aldosterone system, glucose metabolism and diabetes.
    Giacchetti G; Sechi LA; Rilli S; Carey RM
    Trends Endocrinol Metab; 2005 Apr; 16(3):120-6. PubMed ID: 15808810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of protective effects induced by blockade of the renin-angiotensin system: novel role of the pancreatic islet angiotensin-generating system in Type 2 diabetes.
    Leung PS
    Diabet Med; 2007 Feb; 24(2):110-6. PubMed ID: 17257271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical pharmacology of renin-angiotensin system].
    Ueda S
    Nihon Yakurigaku Zasshi; 2008 Mar; 131(3):184-5. PubMed ID: 18421846
    [No Abstract]   [Full Text] [Related]  

  • 34. [The renin-angiotensin system and insulin resistance].
    Rakugi H; Ogihara T
    Nihon Rinsho; 2005 Mar; 63 Suppl 3():89-95. PubMed ID: 15813050
    [No Abstract]   [Full Text] [Related]  

  • 35. [Insulin, renin-angiotensin system, aldosterone and endothelial dysfunction].
    Rubio-Guerra AF; Durán-Salgado MB
    Rev Med Inst Mex Seguro Soc; 2011; 49(6):581-4. PubMed ID: 22176818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The renin-angiotensin system and insulin resistance.
    Liu Z
    Curr Diab Rep; 2007 Feb; 7(1):34-42. PubMed ID: 17254516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pathology and treatment of renin-angiotensin system 2. Chronic kidney disease and the renin-angiotensin system.
    Kimura G
    Intern Med; 2007; 46(16):1295-8. PubMed ID: 17704608
    [No Abstract]   [Full Text] [Related]  

  • 38. Insulin resistance and cardiovascular disease.
    Egan BM; Greene EL; Goodfriend TL
    Am J Hypertens; 2001 Jun; 14(6 Pt 2):116S-125S. PubMed ID: 11411746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D, the renin-angiotensin system, and insulin resistance.
    Rammos G; Tseke P; Ziakka S
    Int Urol Nephrol; 2008; 40(2):419-26. PubMed ID: 18193490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diabetic cardiomyopathy/heart failure: news regarding etiology, diagnosis, therapy].
    Stratmann B; Worms J; Tschoepe D
    Dtsch Med Wochenschr; 2014 Oct; 139(40):2006-9. PubMed ID: 25254396
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.